This study evaluated the use of infant pulmonary function testing (iPFT) to guide diagnosis and treatment of post-infectious bronchiolitis obliterans (PIBO) in young children, examining how objective lung function data can inform clinical decision-making.
Infant pulmonary function testing provided actionable physiologic data that helped guide treatment decisions in PIBO, though specific numeric outcomes (e.g., response rates or lung function thresholds) are not extractable from the available abstract metadata.
Full text was not available for extraction; specific sample size, comparator group details, and quantitative outcome data could not be confirmed. The study may reflect a single-center or small-cohort experience, which would limit generalizability.
In infants suspected of having PIBO, incorporating iPFT into the diagnostic workup may offer objective evidence to guide and monitor treatment decisions. Clinicians should consider iPFT as a complementary tool alongside clinical and radiologic assessment.
Explore related topics
